Download the application note to learn more about how to implement scalable and robust AAV production and purification strategies

In this application note we provide data on the production, purification, and characterization of an AAV6 anti‑CD19 chimeric antigen receptor (AAV6‑CD19CAR) at the 50 L scale using the CTS AAV-MAX system and DynaDrive Single Use Bioreactors. Detailed protocols and troubleshooting guidance are provided to facilitate implementation of these AAV production and purification strategies.

(*Indicates a mandatory field)